This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.

"The 'new biology' that Mittra writes about will impact all our lives in multiple ways. He provides an original and convincing analysis of the complex organizational and institutional architecture emerging around the science and technology, and provides a fascinating and useful conceptual apparatus to help us think about how we should value new products and processes. I highly recommend The New Health Bioeconomy for all students, academics, researchers, and policy thinkers, whose worlds are being changed by this new science and technology." - Joanna Chataway, Director, Innovation, Health and Science Group, RAND Europe, and Professor of Biotechnology and Development, Open University, UK

"Today we are in the midst of a turbulent period in the transformation of the way health benefits are delivered through targeted science. Mittra does a great service in this book. He reconceptualises the health bioeconomy, drawing on considerable empirical analysis and emphasising the quintessential interdisciplinarity of the area, as well as how society is redefining value. All those engaged in this field should read The New Health Bioeconomy - it contains significant wisdom and points a way forward that promises tangible benefit to humankind, as well as economic success." - Iain Gillespie, Professor, Innogen Institute, University of Edinburgh, UK, and former Head of the Biotechnology Division, Organisation for Economic Co-operation and Development

"This is an important, provocative and exciting book. Built on rigorous and innovative research, it challenges conventional wisdom and raises fundamental questions about how the new biology-based research is transforming healthcare, the economy, and society as a whole. " - Luigi Orsenigo, Professor of Applied Economics, Institute for Advanced Studies of Pavia, Italy

Autorentext
James Mittra is a Senior Research Fellow and Deputy Director of the Innogen Institute, based within Science, Technology and Innovation Studies at the University of Edinburgh, UK. He is an interdisciplinary researcher who has published widely on the bioeconomy.

Inhalt

1. New Biology and the Foundations of a Health Bioeconomy
   
   2. Crisis in the Pharmaceutical Industry and the Promise of New Biology
   3. The 'Broken Middle' of Health Innovation
   4. Organizational Transformations and the Value of Interdisciplinarity
   5. Regulation, Policy and Governance of Advanced Therapies
   6. The Role of Patients and Publics in Health Innovation
   7. Rethinking Value and Expectations in the Health Bioeconomy